Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Achievement and CYP3A5[original query] |
|---|
| Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis and rheumatism 2004 Jul 50 (7): 2202-10. Takada Kazuki, Arefayene Million, Desta Zeruesenay, Yarboro Cheryl H, Boumpas Dimitrios T, Balow James E, Flockhart David A, Illei Gabor |
| Optimization of initial tacrolimus dose using pharmacogenetic testing. Clinical pharmacology and therapeutics 2010 Jun 87 (6): 721-6. Thervet E, Loriot M A, Barbier S, Buchler M, Ficheux M, Choukroun G, Toupance O, Touchard G, Alberti C, Le Pogamp P, Moulin B, Le Meur Y, Heng A E, Subra J F, Beaune P, Legendre |
| CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. Transplantation 2010 Dec 90 (12): 1394-400. Min Sang-Il, Kim Seong Yup, Ahn Sang Hyun, Min Seung-Kee, Kim Si Hwa, Kim Yon Su, Moon Kyung Chul, Oh Jung Mi, Kim Sang Joon, Ha Jongw |
| CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel. Breast cancer research and treatment 2012 Jul 134 (1): 401-10. Hertz Daniel L, Motsinger-Reif Alison A, Drobish Amy, Winham Stacey J, McLeod Howard L, Carey Lisa A, Dees E Clai |
| Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus. Journal of gastroenterology and hepatology 2014 Jan 29 (1): 60-6. Hirai Fumihito, Takatsu Noritaka, Yano Yutaka, Satou Yuhou, Takahashi Haruhiko, Ishikawa Satoshi, Tsurumi Kozue, Hisabe Takashi, Matsui Toshiyu |
| Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. Pharmacogenetics and genomics 2014 Dec 24 (12): 597-606. Kuypers Dirk R J, de Loor Henriette, Naesens Maarten, Coopmans Tamara, de Jonge Hyl |
| CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment. Pharmacogenomics and personalized medicine 2018 11 23-33. Chen Lucy, Prasad G V Rame |
| Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period. Transplantation proceedings 2018 11 50 (9): 2684-2689. Kato H, Usui M, Muraki Y, Okuda M, Nakatani K, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji |
| The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
| Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients. British journal of clinical pharmacology 2019 May . Anutrakulchai Sirirat, Pongskul Cholatip, Kritmetapak Kittrawee, Limwattananon Chulaporn, Vannaprasaht Su |
| Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms. European journal of clinical pharmacology 2020 Aug . Wang Junyan, Huang Lingfei, Gao Peng, Hu Yan, Ni Yinghua, Zhu Zhengyi, Zhang Liwen, Yang Jufei, Zhang Huifen, Fang L |
| Pharmacokinetics of a once-daily tacrolimus formulation in first nations and caucasian liver transplant recipients. Transplant international : official journal of the European Society for Organ Transplantation 2021 Jul . Peretz David, On Ngoc H, Miller Donald, Kim Richard, Franklin Carla, Dascal Roman, Knowles Cori, Minuk Gerald |
| Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients. Scientific reports 2021 Jan 11 (1): 443. Pinon Michele, De Nicolò Amedeo, Pizzol Antonio, Antonucci Miriam, D'Avolio Antonio, Serpe Loredana, Dell'Olio Dominic, Catalano Silvia, Tandoi Francesco, Romagnoli Renato, Canaparo Roberto, Calvo Pier Lui |
| Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants. Journal of personalized medicine 2022 5 12 (5): . Sridharan Kannan, Shah Shamik, Jassim Anfal, Hammad Mona, Ebrahim Al Gadhban Johaina, Al Segai O |
| Renal Cyp3a5-Expressing Genotype Decreases Tacrolimus-to-Dose Ratio in Small Cohort of Renal Transplant Recipients-Preliminary Report. Transplantation proceedings 2022 May . Warzyszy?ska Karola, Zawistowski Micha?, Karpeta Edyta, Ja?brzykowska Agnieszka, Kosieradzki Maci |
- Page last reviewed:Feb 1, 2024
- Content source: